DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Issue 11 · Volume 70 · 1993 DOI: 10.1055/s-009-45156

Editorial

724
Hemker, H C; Béguin, S: Standard and Method Independent Units for Heparin Anticoagulant Activities

Obituary

729
Lormeau, Jean-Claude; Petitou, Maurice: Jean Choay 1923-1993

Clinical Studies

730
Toulon, P; Lamine, M; Ledjev, I; Guez, T; Holleman, M E; Sereni, D; Sicard, D: Heparin Cofactor II Deficiency in Patients Infected with the Human Immunodeficiency Virus
736
Bellucci, S; Ignatova, E; Jaillet, N; Boffa, M C: Platelet Hyperactivation in Patients with Essential Thrombocythemia Is not Associated with Vascular Endothelial Cell Damage as Judged by the Level of Plasma Thrombomodulin, Protein S, PAI-1, t-PA and vWF
743
Pyke, Stephen D M; Thompson, Simon G; Buchwalsky, Rainer; Kienast, Jochen; on behalf of the ECAT Angina Pectoris Study Group: Variability over Time of Haemostatic and Other Cardiovascular Risk Factors in Patients Suffering from Angina Pectoris
747
Gandrille, Sophie; Jude, Brigitte; Alhenc-Gelas, Martine; Millaire, Alain; Aiach, Martine: Compound Heterozygosity in a Family with Protein C Deficiency Illustrating the Complexity of the Underlying Molecular Mechanism
753
Green, David; Rademaker, Alfred W; Briët, Ernest: A Prospective, Randomized Trial of Prednisone and Cyclophosphamide in the Treatment of Patients with Factor VIII Autoantibodies
758
Federici, A B; Mannucci, P M; Fogato, E; Ghidoni, P; Matturri, L: Autopsy Findings in Three Patients with von Willebrand Disease Type IIB and Type III: Presence of Atherosclerotic Lesions without Occlusive Arterial Thrombi
762
Conlan, Maureen G; Folsom, Aaron R; Finch, Andrea; Davis, C E; Sorlie, Paul; Wu, Kenneth K; For the ARIC Study Investigators: Correlation of Plasma Protein C Levels with Cardiovascular Risk Factors in Middle-Aged Adults: The Atherosclerosis Risk in Communities (ARIC) Study
768
Berntorp, Erik; Björkman, Sven; Carlsson, Maj; Lethagen, Stefan; Nilsson, Inga Marie: Biochemical and In Vivo Properties of High Purity Factor IX Concentrates
774
Wollina, Karin; Bowen, D J; Syrbe, G; Zintl, F: Female Twins with Severe Christmas Disease (Hemophilia B)

Primary Haemostasis

777
Brooks, Marjory; Catalfamo, James: Buccal Mucosa Bleeding Time Is Prolonged in Canine Models of Primary Hemostatic Disorders

Coagulation

781
Working Group on Hemostasis of the Société Française de Biologie Clinique: Comparison of a Standardized Procedure with Current Laboratory Practices for the Detection of Lupus Anticoagulant in France
787
Triplett, Douglas A; Barna, Linda K; Unger, Gail A: A Hexagonal (II) Phase Phospholipid Neutralization Assay for Lupus Anticoagulant Identification
794
van den Besselaar, A M. H. P: Multi-Center Study of Replacement of the International Reference Preparation for Thromboplastin, Rabbit, Plain
800
Ternisien, C; Ramani, M; Ollivier, V; Khechai, F; Vu, T; Hakim, J; de Prost, D: Endotoxin-Induced Tissue Factor in Human Monocytes is Dependent upon Protein Kinase C Activation

Platelets

807
Vickers, John D; Perry, Dennis W: A Significant Portion of the Aequorin Luminescent Signal from Stimulated Human and Rabbit Platelets is Due to Exposure of the Aequorin to Calcium in the Suspending Medium
812
Bernat, A; Mares, A M; Defreyn, G; Maffrand, J P; Herbert, J M: Effect of Various Antiplatelet Agents on Acute Arterial Thrombosis in the Rat
817
Carteaux, Jean-P; Steiner, Beat; Roux, Sébastien: Ro 44-9883, a New Non-Peptidic GPIIb-GPIIIa Antagonist Prevents Platelet Loss in a Guinea Pig Model of Extracorporeal Circulation
822
Hoet, B; Arnout, J; Deckmyn, H; Vermylen, J: Synergistic Antiplatelet Effect of Ridogrel, a Combined Thromboxane Receptor Antagonist and Thromboxane Synthase Inhibitor, and UDCG-212, a cAMP-Phosphodiesterase Inhibitor
826
Egbrink, Mirjam G A oude; Tangelder, Geert-Jan; Slaaf, Dick W; Reneman, Robert S: Different Roles of Prostaglandins in Thromboembolic Processes in Arterioles and Venules In Vivo
834
Suehiro, Akira; Oura, Yoshio; Ueda, Motoo; Kakishita, Eizo: Inhibitory Effect of Staphylokinase on Platelet Aggregation
838
Cook, Nigel S; Bruttger, Oliver; Pally, Charles; Hagenbach, Alex: The Effects of Two Synthetic Glycoprotein II b/III a Antagonists, Ro 43-8857 and L-700,462, on Platelet Aggregation and Bleeding in Guinea-Pigs and Dogs: Evidence that Ro 43-8857 Is Orally Active

Fibrinolysis

848
Boomsma, D I; Hennis, B C; van Wees, A G M; Frants, R R; Kluft, C: A Parent-Twin Study of Plasma Levels of Histidine-Rich Glycoprotein (HRG)
852
Gram, J; Declerck, P J; Sidelmann, J; Jespersen, J; Kluft, C: Multicentre Evaluation of Commercial Kit Methods: Plasminogen Activator Inhibitor Activity
858
Declerck, P J; Moreau, H; Jespersen, J; Gram, J; Kluft, C: Multicenter Evaluation of Commercially Available Methods for the Immunological Determination of Plasminogen Activator Inhibitor-1 (PAI-1)
864
Machovich, Raymund; Owen, Whyte G: Facilitation of Plasminogen Activation by a Plasmin Substrate Containing a Lysyl Residue
867
Rijken, Dingeman C; de Munk, Gerard A W; Jie, Annie F H: Interaction of Plasminogen Activators and Plasminogen with Heparin: Effect of Ionic Strength
873
Dörr, P J; Brommer, E J P; Dooijewaard, G; Vemer, H M: Parameters of Fibrinolysis in Peritoneal Fluid and Plasma in Different Stages of the Menstrual Cycle

Scientific And Standardiation Committee Communication

876
Barrowcliffe, Trevor W: Factor VIII and Factor IX Sub-Committee: Recommendations for the Assay of High-Purity Factor VIII Concentrates

Letter to the Editor

878
Girolami, Antonio; Patrassi, Giovanni Maurizio; Schivazappa, Luciano; Sartori, Maria Teresa: Thrombotic and Haemorrhagic Complications in Patients with Heart Valve Prostheses: A More Complex Matter Than Proper Prothrombin Time Ratios
879
Barbui, Tiziano; Cortelazzo, Sergio; Finazzi, Guido; Viero, Piera; Remuzzi, Andrea: Rebuttal to the Letter to the Editor by Dr. A. Girolami
879
Farkas, Jean-Christophe; Brossel, Christine; Boyer, Jean-Marc; Brisset, Denis; Laurian, Claude: Cold-Reactive Platelet Agglutinins
880
Scharrer, Inge; Vigh, Zsolt: Release of von Willebrand Factor after Venous Occlusion – The Importance of Standardization of Venous Occlusion Tests
881
Wieczorek, I; Ludlam, C A: Rebuttal to the Letter to the Editor by Dr. Scharrer et al.